Calcium Binding by Ro 60 Multiple Antigenic Peptides on PVDF Membrane

Part of the Methods in Molecular Biology book series (MIMB, volume 1314)


Antibodies directed against ribonucleoprotein (RNP) particles are observed in systemic lupus erythematosus. Ro RNP particle is one such target. It is composed of a 60 kDa protein (Ro 60 or SS-A) that is non-covalently associated with at least one of the four short uridine-rich RNAs (the hY RNAs). Previously, we showed that multiple antigenic peptides (MAPs) made from the sequence of the Ro 60 autoantigen could be used, using double-immunodiffusion studies, enzyme-linked immunosorbant assay, affinity chromatography, and surface plasmon resonance, to show intramolecular and intermolecular protein–protein interaction within the Ro 60 RNP particle. We also observed that calcium is important in mediating this interaction. We hypothesized, therefore, that 60 kDa Ro is a calcium-binding protein. To investigate this, we electrophoresed 60 kDa Ro MAPs, transferred them to PVDF membrane, and assayed calcium binding using the Quin-2 system. Several Ro 60 MAPs were found to bind calcium using this assay, as well as bovine serum albumin, another calcium-binding protein. However, a MAP constructed from the Sm autoantigen did not bind to calcium. These data, along with our observation regarding the involvement of calcium in protein–protein interaction occurring between Ro 60 antigen and Ro 60 MAPs, makes us propose that Ro 60 antigen is a calcium-binding protein.

Key words

Quin-2 Calcium binding Multiple antigenic peptides Ro ribonucleoprotein Systemic lupus erythematosus 


  1. 1.
    Davies DR, Padlan EA (1990) Antibody-antigen complexes. Annu Rev Biochem 59:439–473PubMedCrossRefGoogle Scholar
  2. 2.
    Harley JB, Scofield RH, Reichlin M (1992) Anti-Ro in Sjögren’s syndrome and systemic lupus erythematosus. Rheum Dis Clin North Am 18:337–358, ReviewPubMedGoogle Scholar
  3. 3.
    Scofield RH, Harley JB (1991) Autoantigenicity of Ro/SSA antigen is related to a protein of vesicular stomatitis virus. Proc Natl Acad Sci U S A 88:3343–3347PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Scofield RH, Kurien BT, Zhang F, Mehta P, Kaufman K, Gross T et al (1999) Protein-protein interaction of the Ro- ribonucleoprotein particle using multiple antigenic peptides. Mol Immunol 36:1093–1106PubMedCrossRefGoogle Scholar
  5. 5.
    Scofield RH, Kurien BT, Gross JK, Reed NB, Taylor AK, Dominguez N et al (2004) Interaction of calcium and Ro60: increase of antigenicity. Mol Immunol 41:809–816PubMedCrossRefGoogle Scholar
  6. 6.
    Maruyama K, Mikawa T, Ebashi S (1984) Detection of calcium binding proteins by 45Ca autoradiography on nitrocellulose membrane after sodium dodecyl sulfate gel electrophoresis. J Biochem 95:511–519PubMedGoogle Scholar
  7. 7.
    Deutscher SL, Harley JB, Keene JD (1988) Molecular analysis of the 60 kD human Ro ribonucleoprotein. Proc Natl Acad Sci U S A 85:9479–9483PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Ben-Chetrit E, Gandy BJ, Tan EM, Sullivan KF (1989) Isolation and characterization of a cDNA clone encoding the 60 kDa component of the human SS-A/Ro ribonucleoprotein autoantigen. J Clin Invest 83:1284–1292PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    James JA, Gross T, Scofield RH, Harley JB (1995) Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B’-derived PPPGMRPP and PPGIRPP induce spliceosome autoimmunity. J Exp Med 181:453–461PubMedCrossRefGoogle Scholar
  10. 10.
    Laemmli UK (1970) Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227:680–685PubMedCrossRefGoogle Scholar
  11. 11.
    Kurien BT, Jackson K, Scofield RH (1998) Immunoblotting of multiple antigenic peptides. Electrophoresis 19:1659–1661PubMedCrossRefGoogle Scholar
  12. 12.
    Kurien BT, Scofield RH (1998) Heat mediated quick Coomassie blue protein staining and destaining of SDS-PAGE gels. Indian J Biochem Biophys 35:385–389PubMedGoogle Scholar
  13. 13.
    Dorri Y, Kurien BT (2010) Environmentally safe removal/disposal of Coomassie Brilliant Blue from gel destain and used gel stain. Anal Biochem 404:193–196PubMedCrossRefGoogle Scholar
  14. 14.
    Kurien BT, Dorri Y (2012) Coomassie Brilliant Blue removal/disposal from gel destain and used gel stain in an environment-friendly manner. Methods Mol Biol 869:607–616PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of MedicineUniversity of Oklahoma Health Sciences CenterOklahoma CityUSA
  2. 2.Arthritis and Clinical Immunology ProgramOklahoma Medical Research FoundationOklahoma CityUSA
  3. 3.Department of Veterans Affairs Medical CenterOklahoma CityUSA
  4. 4.Oklahoma Medical Research FoundationOklahoma CityUSA
  5. 5.Helmholtz-Zentrum Dresden-Rossendorf e.V.Institute of Radiopharmaceutical Cancer ResearchDresdenGermany
  6. 6.Department of RadioimmunologyInstitute of Radiopharmaceutical Cancer ResearchDresdenGermany

Personalised recommendations